The effectiveness of 13-valent pneumococcal vaccine against community acquired pneumonia in young children: a systematic review and meta-analysis
Objective. The present meta-analysis study aimed to evaluate the effectiveness of 13-valent pneumococcal conjugate vaccine (PCV) in reducing the morbidity from pneumonia among children under 5 years old. Material and methods. Cochrane and Medline electronic databases were systematically searched fo...
Main Authors: | Ninel Revenco, Ana-Mihaela Balanuta, Dina Bujor, Adela Horodisteanu-Banuh, Olga Cirstea |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2022-09-01
|
Series: | Romanian Journal of Pediatrics |
Subjects: | |
Online Access: | https://rjp.com.ro/articles/2022.3/RJP_2022_3_Art-05.pdf |
Similar Items
-
Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01) -
Impact of the pneumococcal 10-valent vaccine on reducing hospitalization for community-acquired pneumonia in children
by: Sandra Rodrigues da Silva, et al. -
Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018-10-01) -
23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01) -
Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey
by: Erdem Gönüllü, et al.
Published: (2020-10-01)